|  | 
|  |  | 
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. | 
|   
 Celator Pharmaceuticals Founded in 2000, Celator® Pharmaceuticals is developing advanced therapies to treat cancer. Based on a proprietary technology platform, research at Celator identifies synergistic ratios of drugs to improve tumor cell kill and locks the synergistic ratio in a drug delivery vehicle to maintain the ratio in patients. The goal of this approach is to improve the therapeutic benefit these drugs provide patients. Discussion Board for Celator Pharmaceuticals - CPXX SI Market Page - CPXX | ||||||||||||||
| 
 
 | 
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings | 
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI | 
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |